Studies have shown that FMT can reduce brain amyloid pathology and Tau protein phosphorylation, thereby ameliorating neurodegenerative changes associated with AD (Biazzo and Deidda, 2022; Kim et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.